Obstetrical Medicine Special: Hypertension and Thrombophilia in Pregnancy

Subscribe on iTunes

The CHIPS trial of Hypertension in Pregnancy and TIPPS trial of Thrombophilia in Pregnancy

Janice and Amol want you to understand the following:

1. Tight blood pressure control in pregnancy does not affect fetal outcomes in pregnancy compared with loose blood pressure control. The only difference in maternal outcomes is a reduced risk of severe hypertension in the tight blood pressure control group.

2. Low molecular weight heparin does not improve pregnancy outcomes in women with thrombophilia.

Continuing Medical Education

Internists can receive 0.5 hours of Continuing Medical Education credit for each podcast they listen to through the Canadian Society of Internal Medicine (MOC Category 1) and the American Medical Association (PRA Category 1). To receive CME credit for listening to this podcast, please click here to fill out our Evaluation and Impact Assessment Form.

The papers

LA Magee et al. Less-Tight versus Tight Control of Hypertension in Pregnancy. N Engl J Med. 2015 Jan 29;372(5):407-17. (PubMed).

MA Rodger et al. Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial. Lancet. 2014 Nov 8;384(9955):1673-83. (PubMed).

Good stuff

My Own Life: Oliver Sacks on Learning He Has Terminal Cancer. New York Times. 2015 Feb 19. 

John Evans, founder of MaRS, dead at 85. Marco Chown Oved. Toronto Star. 2015 Feb 13.

Leave a Comment

Your email address will not be published. Required fields are marked *

Republish this article

Republish this article on your website under the creative commons licence.

Learn more